Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Neurochem. 2020 Jul 3;158(1):25–35. doi: 10.1111/jnc.15044

Table 1.

Summary of drugs targeting S1P signaling.

S1PR modulator Molecular target Phase of clinical trial
Fingolimod S1P1, S1P3, S1P4, S1P5 Approved for RRMS
Phase III for PPMS
Siponimod S1P1, S1P5 Phase III for SPMS
Phase I for RRMS
Amiselimod S1P1, S1P4, S1P5 Phase II for RRMS
Ceralifimod S1P1, S1P5 Phase II for RRMS
Ozanimod S1P1, S1P5 Phase III for RRMS
CS-0777 S1P1 Phase I for MS
Ponesimod S1P1 Phase III for RRMS